Douglas W Nespory, DO - Medicare General Surgery in Liberty, MO

Douglas W Nespory, DO is a medicare enrolled "Surgery" physician in Liberty, Missouri. He went to Kansas City University Of Med & Biosciences, College Of Osteo Med and graduated in 1987 and has 37 years of diverse experience with area of expertise as General Surgery. He is a member of the group practice Excelsior Springs City Hospital and his current practice location is 2521 Glenn Hendren Dr, Suite #112, Liberty, Missouri. You can reach out to his office (for appointments etc.) via phone at (816) 781-4007.

Douglas W Nespory is licensed to practice in Missouri (license number R5J39) and he also participates in the medicare program. He accepts medicare assignments (which means he accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance) and his NPI Number is 1568429595.

Contact Information

Douglas W Nespory, DO
2521 Glenn Hendren Dr, Suite #112,
Liberty, MO 64068-3388
(816) 781-4007
(816) 407-1066



Physician's Profile

Full NameDouglas W Nespory
GenderMale
SpecialityGeneral Surgery
Experience37 Years
Location2521 Glenn Hendren Dr, Liberty, Missouri
Accepts Medicare AssignmentsYes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance.
  Medical Education and Training:
  • Douglas W Nespory attended and graduated from Kansas City University Of Med & Biosciences, College Of Osteo Med in 1987
  NPI Data:
  • NPI Number: 1568429595
  • Provider Enumeration Date: 04/26/2006
  • Last Update Date: 10/26/2016
  Medicare PECOS Information:
  • PECOS PAC ID: 5597749523
  • Enrollment ID: I20040625000054

Medical Identifiers

Medical identifiers for Douglas W Nespory such as npi, medicare ID, medicare PIN, medicaid, etc.
IdentifierTypeStateIssuer
1568429595NPI-NPPES
246654415MedicaidMO
246654412MedicaidMO

Medical Taxonomies and Licenses

TaxonomyTypeLicense (State)Status
208600000XSurgery R5J39 (Missouri)Primary

Medical Facilities Affiliation

Facility NameLocationFacility Type
Excelsior Springs HospitalExcelsior springs, MOHospital

Medicare Reassignments

Some practitioners may not bill the customers directly but medicare billing happens through clinics / group practice / hospitals where the provider works. Medicare reassignment of benefits is a mechanism by which practitioners allow third parties to bill and receive payment for medicare services performed by them. Douglas W Nespory allows following entities to bill medicare on his behalf.
Entity NameExcelsior Springs City Hospital
Entity TypePart B Supplier - Clinic/group Practice
Entity IdentifiersNPI Number: 1285733923
PECOS PAC ID: 7315847209
Enrollment ID: O20040108000958

News Archive

BSX receives CE Mark approval for TAXUS Element Paclitaxel-Eluting Coronary Stent System

Boston Scientific Corporation today announced it has received CE Mark approval for its TAXUS Element Paclitaxel-Eluting Coronary Stent System, the Company's third-generation drug-eluting stent technology. This approval includes a specific indication for the treatment of diabetic patients.

Study estimates prevalence of periodontitis at state and local levels across U.S. using SAE method

The International and American Associations for Dental Research have published an article titled "Predicting Periodontitis at State and Local Levels in the United States" in the OnlineFirst portion of the Journal of Dental Research. In it, authors P.I. Eke, X. Zhang, H. Lu, L. Wei, G. Thornton-Evans, K.J. Greenlund, J.B. Holt and J.B. Croft estimate the prevalence of periodontitis at state and local levels across the United States by using a novel, small area estimation (SAE) method.

Study suggests nestin+ cholinergic neurons may have closer connection to olfactory bulb neurons

Dr. Yuhong Zhao and co-workers from Sun Yat-sen University in China explored the projection of nestin+ neurons to the olfactory bulb and the time course of nestin+ neurons in the medial septum-diagonal band of Broca in adult rats during injury recovery after olfactory nerve transection.

Aflibercept drug used for AMD shows no added benefit over current standard therapy

The drug aflibercept (trade name: Eylea) has been approved in Germany since November 2012 for the treatment of wet age-related macular degeneration (AMD). In an early benefit assessment pursuant to the Act on the Reform of the Market for Medicinal Products (AMNOG) the German Institute for Quality and Efficiency in Health Care (IQWiG) examined whether this new drug offers an added benefit over the current standard therapy.

Pre-clinical studies of ID-12 orally-bioavailable inhibitor completes

ChemDiv Inc. of San Diego, and iDialog (Intellektualniy Dialog) of Yaroslavl, Russia, announced today the successful completion of a pre-clinical development and the subsequent nomination of ID-12 as lead clinical development candidate for the treatment of chronic hepatitis C. This novel small molecule orally-bioavailable inhibitor of hepatitis C virus (HCV) blocks early stage of viral infection.

Read more Medical News

› Verified 6 days ago

Entity NameCrowntown General Surgery Pc
Entity TypePart B Supplier - Clinic/group Practice
Entity IdentifiersNPI Number: 1750838421
PECOS PAC ID: 8628358090
Enrollment ID: O20161201001768

News Archive

BSX receives CE Mark approval for TAXUS Element Paclitaxel-Eluting Coronary Stent System

Boston Scientific Corporation today announced it has received CE Mark approval for its TAXUS Element Paclitaxel-Eluting Coronary Stent System, the Company's third-generation drug-eluting stent technology. This approval includes a specific indication for the treatment of diabetic patients.

Study estimates prevalence of periodontitis at state and local levels across U.S. using SAE method

The International and American Associations for Dental Research have published an article titled "Predicting Periodontitis at State and Local Levels in the United States" in the OnlineFirst portion of the Journal of Dental Research. In it, authors P.I. Eke, X. Zhang, H. Lu, L. Wei, G. Thornton-Evans, K.J. Greenlund, J.B. Holt and J.B. Croft estimate the prevalence of periodontitis at state and local levels across the United States by using a novel, small area estimation (SAE) method.

Study suggests nestin+ cholinergic neurons may have closer connection to olfactory bulb neurons

Dr. Yuhong Zhao and co-workers from Sun Yat-sen University in China explored the projection of nestin+ neurons to the olfactory bulb and the time course of nestin+ neurons in the medial septum-diagonal band of Broca in adult rats during injury recovery after olfactory nerve transection.

Aflibercept drug used for AMD shows no added benefit over current standard therapy

The drug aflibercept (trade name: Eylea) has been approved in Germany since November 2012 for the treatment of wet age-related macular degeneration (AMD). In an early benefit assessment pursuant to the Act on the Reform of the Market for Medicinal Products (AMNOG) the German Institute for Quality and Efficiency in Health Care (IQWiG) examined whether this new drug offers an added benefit over the current standard therapy.

Pre-clinical studies of ID-12 orally-bioavailable inhibitor completes

ChemDiv Inc. of San Diego, and iDialog (Intellektualniy Dialog) of Yaroslavl, Russia, announced today the successful completion of a pre-clinical development and the subsequent nomination of ID-12 as lead clinical development candidate for the treatment of chronic hepatitis C. This novel small molecule orally-bioavailable inhibitor of hepatitis C virus (HCV) blocks early stage of viral infection.

Read more Medical News

› Verified 6 days ago

Medicare Part D Prescriber Enrollment

Any physician or other eligible professional who prescribes Part D drugs must either enroll in the Medicare program or opt out in order to prescribe drugs to their patients with Part D prescription drug benefit plans. Douglas W Nespory is enrolled with medicare and thus, if eligible, can prescribe medicare part D drugs to patients with medicare part D benefits.

Mailing Address and Practice Location

Mailing AddressPractice Location Address
Douglas W Nespory, DO
2521 Glenn Hendren Dr, Suite #112,
Liberty, MO 64068-3388

Ph: (816) 781-4007
Douglas W Nespory, DO
2521 Glenn Hendren Dr, Suite #112,
Liberty, MO 64068-3388

Ph: (816) 781-4007

News Archive

BSX receives CE Mark approval for TAXUS Element Paclitaxel-Eluting Coronary Stent System

Boston Scientific Corporation today announced it has received CE Mark approval for its TAXUS Element Paclitaxel-Eluting Coronary Stent System, the Company's third-generation drug-eluting stent technology. This approval includes a specific indication for the treatment of diabetic patients.

Study estimates prevalence of periodontitis at state and local levels across U.S. using SAE method

The International and American Associations for Dental Research have published an article titled "Predicting Periodontitis at State and Local Levels in the United States" in the OnlineFirst portion of the Journal of Dental Research. In it, authors P.I. Eke, X. Zhang, H. Lu, L. Wei, G. Thornton-Evans, K.J. Greenlund, J.B. Holt and J.B. Croft estimate the prevalence of periodontitis at state and local levels across the United States by using a novel, small area estimation (SAE) method.

Study suggests nestin+ cholinergic neurons may have closer connection to olfactory bulb neurons

Dr. Yuhong Zhao and co-workers from Sun Yat-sen University in China explored the projection of nestin+ neurons to the olfactory bulb and the time course of nestin+ neurons in the medial septum-diagonal band of Broca in adult rats during injury recovery after olfactory nerve transection.

Aflibercept drug used for AMD shows no added benefit over current standard therapy

The drug aflibercept (trade name: Eylea) has been approved in Germany since November 2012 for the treatment of wet age-related macular degeneration (AMD). In an early benefit assessment pursuant to the Act on the Reform of the Market for Medicinal Products (AMNOG) the German Institute for Quality and Efficiency in Health Care (IQWiG) examined whether this new drug offers an added benefit over the current standard therapy.

Pre-clinical studies of ID-12 orally-bioavailable inhibitor completes

ChemDiv Inc. of San Diego, and iDialog (Intellektualniy Dialog) of Yaroslavl, Russia, announced today the successful completion of a pre-clinical development and the subsequent nomination of ID-12 as lead clinical development candidate for the treatment of chronic hepatitis C. This novel small molecule orally-bioavailable inhibitor of hepatitis C virus (HCV) blocks early stage of viral infection.

Read more News

› Verified 6 days ago


Surgery Doctors in Liberty, MO

Dr. Clayton Lewis Theleman, M.D.
Surgery
Medicare: Accepting Medicare Assignments
Practice Location: 2521 Glenn Hendren Dr Ste 108, Liberty, MO 64068
Phone: 816-781-3515    Fax: 816-781-3517
Dr. Kirstie Schneider Van Ry, M.D.
Surgery
Medicare: Accepting Medicare Assignments
Practice Location: 2521 Glenn Hendren Dr, Ste 108, Liberty, MO 64068
Phone: 816-781-7200    Fax: 816-781-6973
Brett Lee Wilson, PA
Surgery
Medicare: Accepting Medicare Assignments
Practice Location: 2521 Glenn Hendren Dr Ste 204, Liberty, MO 64068
Phone: 816-781-6066    
Alan William Good, MD
Surgery
Medicare: Medicare Enrolled
Practice Location: 2521 Glenn Hendren Dr Ste 108, Liberty, MO 64068
Phone: 816-781-3515    Fax: 816-781-3517
Dr. Charles William Beggs, M.D.
Surgery
Medicare: Medicare Enrolled
Practice Location: 2521 Glenn Hendren Dr, Suite 108, Liberty, MO 64068
Phone: 816-781-3515    Fax: 816-781-3517
Michael Earl Gorton, MD
Surgery
Medicare: Accepting Medicare Assignments
Practice Location: 2521 Glenn Hendren Dr, Suite 306, Liberty, MO 64068
Phone: 816-407-5490    Fax: 816-407-5491

Find & Compare Providers Near You: Find and compare doctors, nursing homes, hospitals, and other health care providers in your area that accept Medicare. Get information like: Find a doctor or clinician that accepts Medicare near you.

Doctors and clinicians: Doctors and clinicians include doctors, clinicians and groups who are qualified to practice in many specialties. Each specialty focuses on certain parts of the body, periods of life, conditions, or primary care. The doctors, clinicians, and groups listed here typically work in an office or clinic setting. Also those who currently accept Medicare are included.

Hospitals: Find information about Medicare-certified hospitals and long-term care hospitals in your area, including Veterans Administration medical centers and military hospitals, across the country. Long-term care hospitals serve critically ill and medically complex patients who require extended hospital care.

Data provided: Information on www.medicareusa.org is built using open data sources published by Centers for Medicare & Medicaid Services (CMS) under Freedom of Information Act (FOIA).

© 2024 MedicareUsa. All rights reserved. Maintained by the Agency for Healthcare Research and Quality, U.S. Department of Health and Human Services.